Annual EBITDA
-$101.68 M
-$40.68 M-66.69%
December 31, 2023
Summary
- As of February 7, 2025, TERN annual EBITDA is -$101.68 million, with the most recent change of -$40.68 million (-66.69%) on December 31, 2023.
- During the last 3 years, TERN annual EBITDA has fallen by -$65.05 million (-177.57%).
- TERN annual EBITDA is now -452.89% below its all-time high of -$18.39 million, reached on December 31, 2018.
Performance
TERN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$24.73 M
+$564.00 K+2.23%
September 30, 2024
Summary
- As of February 7, 2025, TERN quarterly EBITDA is -$24.73 million, with the most recent change of +$564.00 thousand (+2.23%) on September 30, 2024.
- Over the past year, TERN quarterly EBITDA has dropped by -$895.00 thousand (-3.75%).
- TERN quarterly EBITDA is now -186.39% below its all-time high of -$8.64 million, reached on September 30, 2020.
Performance
TERN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$99.08 M
+$8.23 M+7.67%
September 30, 2024
Summary
- As of February 7, 2025, TERN TTM EBITDA is -$99.08 million, with the most recent change of +$8.23 million (+7.67%) on September 30, 2024.
- Over the past year, TERN TTM EBITDA has increased by +$2.60 million (+2.56%).
- TERN TTM EBITDA is now -903.73% below its all-time high of -$9.87 million, reached on December 31, 2019.
Performance
TERN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TERN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -66.7% | -3.8% | +2.6% |
| 3 y3 years | -177.6% | -3.8% | +2.6% |
| 5 y5 years | -452.9% | -3.8% | +2.6% |
TERN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -106.0% | at low | -82.6% | +25.0% | -100.8% | +7.7% |
| 5 y | 5-year | -177.6% | at low | -186.4% | +25.0% | -903.7% | +7.7% |
| alltime | all time | -452.9% | at low | -186.4% | +25.0% | -903.7% | +7.7% |
Terns Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$24.73 M(-2.2%) | -$99.08 M(-7.7%) |
| Jun 2024 | - | -$25.30 M(+0.3%) | -$107.31 M(+4.2%) |
| Mar 2024 | - | -$25.21 M(+5.8%) | -$102.95 M(+1.3%) |
| Dec 2023 | -$101.68 M(+66.7%) | -$23.84 M(-27.7%) | -$101.68 M(+7.7%) |
| Sep 2023 | - | -$32.96 M(+57.4%) | -$94.43 M(+20.3%) |
| Jun 2023 | - | -$20.94 M(-12.5%) | -$78.51 M(+10.0%) |
| Mar 2023 | - | -$23.93 M(+44.2%) | -$71.39 M(+17.0%) |
| Dec 2022 | -$61.00 M | -$16.59 M(-2.6%) | -$61.00 M(+4.9%) |
| Sep 2022 | - | -$17.04 M(+23.3%) | -$58.17 M(+10.0%) |
| Jun 2022 | - | -$13.81 M(+2.0%) | -$52.89 M(+6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$13.55 M(-1.6%) | -$49.77 M(+0.9%) |
| Dec 2021 | -$49.35 M(+34.7%) | -$13.76 M(+17.0%) | -$49.35 M(+11.5%) |
| Sep 2021 | - | -$11.76 M(+9.9%) | -$44.25 M(+7.6%) |
| Jun 2021 | - | -$10.70 M(-18.5%) | -$41.12 M(+1.7%) |
| Mar 2021 | - | -$13.12 M(+51.5%) | -$40.42 M(+10.3%) |
| Dec 2020 | -$36.63 M(-47.7%) | -$8.66 M(+0.3%) | -$36.63 M(-3.2%) |
| Sep 2020 | - | -$8.64 M(-13.6%) | -$37.84 M(+29.6%) |
| Jun 2020 | - | -$10.00 M(+7.1%) | -$29.20 M(+52.1%) |
| Mar 2020 | - | -$9.34 M(-5.4%) | -$19.21 M(+94.6%) |
| Dec 2019 | -$70.00 M(+280.7%) | -$9.87 M | -$9.87 M |
| Dec 2018 | -$18.39 M | - | - |
FAQ
- What is Terns Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals annual EBITDA year-on-year change?
- What is Terns Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Terns Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals TTM EBITDA year-on-year change?
What is Terns Pharmaceuticals annual EBITDA?
The current annual EBITDA of TERN is -$101.68 M
What is the all time high annual EBITDA for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high annual EBITDA is -$18.39 M
What is Terns Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, TERN annual EBITDA has changed by -$40.68 M (-66.69%)
What is Terns Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of TERN is -$24.73 M
What is the all time high quarterly EBITDA for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high quarterly EBITDA is -$8.64 M
What is Terns Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, TERN quarterly EBITDA has changed by -$895.00 K (-3.75%)
What is Terns Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of TERN is -$99.08 M
What is the all time high TTM EBITDA for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high TTM EBITDA is -$9.87 M
What is Terns Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, TERN TTM EBITDA has changed by +$2.60 M (+2.56%)